P1.16-43 Analyses of Long-Term Outcomes and Prognostic Factors in Surgically Resected ALK-Rearranged Lung Adenocarcinoma

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.16-31 Surgically Resected Acinar Adenocarcinoma of the Lung: Analysis of Different Prognostic Groups

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.01-81 Long-Term Outcome of Surgically Resected Unsuspected N2 Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Significance of IMMT Expression in Surgically‐resected Lung Adenocarcinoma

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Uncommon Features of Surgically Resected ALK-positive Cavitary Lung Adenocarcinoma: A Case Report

Surgical Case Reports
2017English

Prognostic Significance of XB130 Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma

World Journal of Surgical Oncology
SurgeryOncology
2014English

P2.01-97 Prognostic Factors in Resected Lung Mucinous Adenocarcinoma: Clinical and Pathological Features

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.16-03 Uncommon EGFR Mutations as a Worse Prognostic Factor for Surgically Resected Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Complete Pathological Response to Crizotinib in a Patient With ALK-rearranged Lung Adenocarcinoma

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

P1.16-10 Marginal Features Analyses of Lung Adenocarcinoma for Survival Prediction

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy